Following publication of the original article [1], we have been informed that one exclusion criteria needs to be changed: “Prior surgeries to address postamputation pain” should read “Prior RPNI or TMR surgery of the nerve to be treated (with painful neuroma) to address postamputation pain.” In patient selection (last sentence in paragraph “Distinguishing residual limb pain, neuroma pain, and phantom limb pain” on page 6), “The following methods should be applied to document the presence of neuroma pain: compatible symptomatology, Tinel's sign test, imaging (ultrasound or MRI), and nerve block.” Should read “At least one of the following methods should be applied to document the presence of neuroma pain: compatible symptomatology, Tinel's sign test, imaging (ultrasound or MRI), or nerve block.” “Prior surgeries to address postamputation pain” should read “Prior RPNI or TMR surgery of the nerve to be treated (with painful neuroma) to address postamputation pain.” In patient selection (last sentence in paragraph “Distinguishing residual limb pain, neuroma pain, and phantom limb pain” on page 6), “The following methods should be applied to document the presence of neuroma pain: compatible symptomatology, Tinel's sign test, imaging (ultrasound or MRI), and nerve block.” Should read “At least one of the following methods should be applied to document the presence of neuroma pain: compatible symptomatology, Tinel's sign test, imaging (ultrasound or MRI), or nerve block.” The sponsor has been changed in the trial from Chalmers University of Technology to Center for Bionics and Pain Research. Therefore, the disclaimer was also updated. The original article has been corrected.
Pettersen E., Sassu P., Reinholdt C., Dahm P., Rolfson O., Bjorkman A., et al. (2023). Correction: Surgical treatments for postamputation pain: study protocol for an international, double-blind, randomised controlled trial (Trials, (2023), 24, 1, (304), 10.1186/s13063-023-07286-0). TRIALS, 24(1), 654-2 [10.1186/s13063-023-07626-0].
Correction: Surgical treatments for postamputation pain: study protocol for an international, double-blind, randomised controlled trial (Trials, (2023), 24, 1, (304), 10.1186/s13063-023-07286-0)
Innocenti M.;Pedrini F. A.;
2023
Abstract
Following publication of the original article [1], we have been informed that one exclusion criteria needs to be changed: “Prior surgeries to address postamputation pain” should read “Prior RPNI or TMR surgery of the nerve to be treated (with painful neuroma) to address postamputation pain.” In patient selection (last sentence in paragraph “Distinguishing residual limb pain, neuroma pain, and phantom limb pain” on page 6), “The following methods should be applied to document the presence of neuroma pain: compatible symptomatology, Tinel's sign test, imaging (ultrasound or MRI), and nerve block.” Should read “At least one of the following methods should be applied to document the presence of neuroma pain: compatible symptomatology, Tinel's sign test, imaging (ultrasound or MRI), or nerve block.” “Prior surgeries to address postamputation pain” should read “Prior RPNI or TMR surgery of the nerve to be treated (with painful neuroma) to address postamputation pain.” In patient selection (last sentence in paragraph “Distinguishing residual limb pain, neuroma pain, and phantom limb pain” on page 6), “The following methods should be applied to document the presence of neuroma pain: compatible symptomatology, Tinel's sign test, imaging (ultrasound or MRI), and nerve block.” Should read “At least one of the following methods should be applied to document the presence of neuroma pain: compatible symptomatology, Tinel's sign test, imaging (ultrasound or MRI), or nerve block.” The sponsor has been changed in the trial from Chalmers University of Technology to Center for Bionics and Pain Research. Therefore, the disclaimer was also updated. The original article has been corrected.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
